Vivo Capital Fund VIII L.P. 13D/13G Filings for Aligos Therapeutics, Inc. (ALGS)

Vivo Capital Fund VIII L.P. 13D and 13G filings for Aligos Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
6:57 pm
Purchase		 2024-09-30 13G Aligos Therapeutics, Inc.
ALGS		 Vivo Capital Fund VIII L.P. 141,879
4.000%		 141,879increase
(New Position)		 Filing